Cite

    Michael E Thase et al.. “Efficacy and safety of brexpiprazole as adjunctive treatment in major depressive disorder: overview of four short-term studies.” Expert opinion on pharmacotherapy, vol. 20, 2019, pp. 1907–1916. http://access.bl.uk/ark:/81055/vdc_100099954921.0x00003c